Swiss Ambassador to Armenia Lukas Gasser: Switzerland will try to contribute to a peaceful settlement of the Nagorno-Karabakh conflict without questioning the established formats such as the OSCE Minsk process
by Arthur Yernjakyan
The share of pharma drugs of local production in Armenia grew by 10% for the last 3-4 years versus the former 5-7%, Director General of one of the leading pharmaceutical companies "Likvor", Sergey Matevosyan, said at today's press-conference.
He said that 17 companies have got a license for pharma drugs production, 7 of which provide the biggest volume of production and 5-6 companies export their production. He also added that half of the pharma drugs produced in Armenia are exported chiefly to the CIS countries.
The pharma drugs production in Armenia for January-August 2013 versus January-August 2012 grew by 37,4% - up to 3,28 bln drams versus 3,5 bln drams in 2012, and their export for the reported period grew by 56,4% - up to 1,7 bln drams. He also added that the requirement to raise the quality of the pharma drugs was also dictated by the decision of the Armenian government to pass to the European Standards GMP (Good Manufacturing Practice). The three Armenian companies - Farmatek, Likvor and Arkhimed will complete passing to the GMP standards by the end of 2013, he said.